157 related articles for article (PubMed ID: 8444504)
1. Biological risk factors for restenosis after percutaneous transluminal coronary angioplasty.
Benchimol D; Bonnet J; Benchimol H; Drouillet F; Duplaa C; Couffinhal T; Desgranges C; Bricaud H
Int J Cardiol; 1993 Jan; 38(1):7-18. PubMed ID: 8444504
[TBL] [Abstract][Full Text] [Related]
2. Absence of a prothrombotic state in restenotic patients?
Brack MJ; More RS; Pringle S; Gershlick AH
Coron Artery Dis; 1994 Jun; 5(6):501-6. PubMed ID: 7952409
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of hemostatic factors for sudden death in patients with stable angina pectoris.
Benchimol D; Dartigues JF; Benchimol H; Drouillet F; Lauribe P; Marazanof M; Couffinhal T; Bonnet J
Am J Cardiol; 1995 Aug; 76(4):241-4. PubMed ID: 7618616
[TBL] [Abstract][Full Text] [Related]
4. Biological risk factors for sudden death in patients with coronary artery disease and without heart failure.
Lauribe P; Benchimol D; Dartigues JF; Dada S; Benchimol H; Drouillet F; Bonnet J; Bricaud H
Int J Cardiol; 1992 Mar; 34(3):307-18. PubMed ID: 1563856
[TBL] [Abstract][Full Text] [Related]
5. The influence of coronary angiography and angioplasty on parameters of hemostasis and fibrinolysis.
Six AJ; Tjon RM; Buys EM; Haas F; Hollander-van Zalk A; Haverkate F
Thromb Haemost; 1990 Aug; 64(1):113-6. PubMed ID: 2148844
[TBL] [Abstract][Full Text] [Related]
6. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
[TBL] [Abstract][Full Text] [Related]
7. Restenosis after transluminal coronary angioplasty: a risk factor analysis.
Gürlek A; Dağalp Z; Oral D; Omürlü K; Erol C; Akyol T; Tutar E
J Cardiovasc Risk; 1995 Feb; 2(1):51-5. PubMed ID: 7606641
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: effects on inflammatory, hemostatic, and endothelium-derived parameters.
Suzuki S; Matsuo T; Kobayashi H; Matsuo M; Shimamo C; Koide M; Sakamoto S
Thromb Res; 2000 May; 98(4):269-79. PubMed ID: 10822073
[TBL] [Abstract][Full Text] [Related]
9. Influence of continued smoking and some biological risk factors on restenosis after percutaneous transluminal coronary angioplasty.
Kotamäki M; Laustiola K; Syvänne M; Heikkilä J
J Intern Med; 1996 Nov; 240(5):293-301. PubMed ID: 8946812
[TBL] [Abstract][Full Text] [Related]
10. Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis.
Ishiwata S; Tukada T; Nakanishi S; Nishiyama S; Seki A
Am Heart J; 1997 Apr; 133(4):387-92. PubMed ID: 9124158
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen after coronary angioplasty as a risk factor for restenosis.
Montalescot G; Ankri A; Vicaut E; Drobinski G; Grosgogeat Y; Thomas D
Circulation; 1995 Jul; 92(1):31-8. PubMed ID: 7788913
[TBL] [Abstract][Full Text] [Related]
12. Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty.
Bertrand ME; McFadden EP; Fruchart JC; Van Belle E; Commeau P; Grollier G; Bassand JP; Machecourt J; Cassagnes J; Mossard JM; Vacheron A; Castaigne A; Danchin N; Lablanche JM
J Am Coll Cardiol; 1997 Oct; 30(4):863-9. PubMed ID: 9316510
[TBL] [Abstract][Full Text] [Related]
13. Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis.
Strauss BH; Lau HK; Bowman KA; Sparkes J; Chisholm RJ; Garvey MB; Fenkell LL; Natarajan MK; Singh I; Teitel JM
Circulation; 1999 Oct; 100(15):1616-22. PubMed ID: 10517732
[TBL] [Abstract][Full Text] [Related]
14. Restenosis or rapid progression in non-dilated sites are not predictors of late spontaneous coronary events.
Benchimol D; Dubroca B; Dufourq P; Benchimol H; Couffinhal T; Dartigues JF; Bonnet J
Int J Cardiol; 1997 Jul; 60(2):201-11. PubMed ID: 9226292
[TBL] [Abstract][Full Text] [Related]
15. Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: quantitative angiographic analysis in 778 lesions--further evidence for the restenosis paradox. MERCATOR Study Group (Multicenter European Research trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
Hermans WR; Foley DP; Rensing BJ; Serruys PW
Am Heart J; 1994 Mar; 127(3):483-94. PubMed ID: 8122593
[TBL] [Abstract][Full Text] [Related]
16. Clinical and angiographic results of transluminal extraction coronary atherectomy in saphenous vein bypass grafts.
Safian RD; Grines CL; May MA; Lichtenberg A; Juran N; Schreiber TL; Pavlides G; Meany TB; Savas V; O'Neill WW
Circulation; 1994 Jan; 89(1):302-12. PubMed ID: 8281662
[TBL] [Abstract][Full Text] [Related]
17. Serum lipids and restenosis after successful percutaneous transluminal coronary angioplasty. Ichilov Magnesium Study Group.
Roth A; Eshchar Y; Keren G; Sheps D; Kerbal S; Laniado S; Miller HI; Rubinstein A
Am J Cardiol; 1994 Jun; 73(16):1154-8. PubMed ID: 8203331
[TBL] [Abstract][Full Text] [Related]
18. Angioscopic prediction of successful dilatation and of restenosis in percutaneous transluminal coronary angioplasty. Significance of yellow plaque.
Itoh A; Miyazaki S; Nonogi H; Daikoku S; Haze K
Circulation; 1995 Mar; 91(5):1389-96. PubMed ID: 7867178
[TBL] [Abstract][Full Text] [Related]
19. Progression of coronary artery disease in non-dilated sites in the months following balloon angioplasty: time-dependent relation with restenosis.
Benchimol D; Dartigues JF; Benchimol H; Bordier P; Duplàa C; Couffinhal T; Bonnet J
Eur J Clin Invest; 1995 Dec; 25(12):935-41. PubMed ID: 8719934
[TBL] [Abstract][Full Text] [Related]
20. Impact of tranilast on restenosis after coronary angioplasty: tranilast restenosis following angioplasty trial (TREAT).
Tamai H; Katoh O; Suzuki S; Fujii K; Aizawa T; Takase Si; Kurogane H; Nishikawa H; Sone T; Sakai K; Suzuki T
Am Heart J; 1999 Nov; 138(5 Pt 1):968-75. PubMed ID: 10539831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
